These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 30528650

  • 1. 'Frequently recurring' nocturnal polyuria is predictive of response to desmopressin in monosymptomatic nocturnal enuresis in childhood.
    Marzuillo P, Marotta R, Guarino S, Fedele MC, Palladino F, Capalbo D, Della Vecchia N, Miraglia Del Giudice E, Polito C, La Manna A.
    J Pediatr Urol; 2019 Apr; 15(2):166.e1-166.e7. PubMed ID: 30528650
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Combination therapy (desmopressin plus oxybutynin) improves the response rate compared with desmopressin alone in patients with monosymptomatic nocturnal enuresis and nocturnal polyuria and absence of constipation predict the response to this treatment.
    Capalbo D, Guarino S, Di Sessa A, Esposito C, Grella C, Papparella A, Miraglia Del Giudice E, Marzuillo P.
    Eur J Pediatr; 2023 Apr; 182(4):1587-1592. PubMed ID: 36693995
    [Abstract] [Full Text] [Related]

  • 5. Partial response to intranasal desmopressin in children with monosymptomatic nocturnal enuresis is related to persistent nocturnal polyuria on wet nights.
    Raes A, Dehoorne J, Van Laecke E, Hoebeke P, Vande Walle C, Vansintjan P, Donckerwolcke R, Vande Walle J.
    J Urol; 2007 Sep; 178(3 Pt 1):1048-51; discussion 1051-2. PubMed ID: 17632162
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Reduced anti-diuretic response to desmopressin during wet nights in patients with monosymptomatic nocturnal enuresis.
    Tauris LH, Andersen RF, Kamperis K, Hagstroem S, Rittig S.
    J Pediatr Urol; 2012 Jun; 8(3):285-90. PubMed ID: 21514237
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tailoring treatment of monosymptomatic nocturnal enuresis: the role of maximum voided capacity.
    Tauris LH, Kamperis K, Hagstroem S, Bower WF, Rittig S.
    J Urol; 2012 Feb; 187(2):664-9. PubMed ID: 22177206
    [Abstract] [Full Text] [Related]

  • 13. Combination treatment of nocturnal enuresis with desmopressin and indomethacin.
    Kamperis K, Hagstroem S, Faerch M, Mahler B, Rittig S, Djurhuus JC.
    Pediatr Nephrol; 2017 Apr; 32(4):627-633. PubMed ID: 27787700
    [Abstract] [Full Text] [Related]

  • 14. Increased renal concentrating ability after long-term oral desmopressin lyophilisate treatment contributes to continued success for monosymptomatic nocturnal enuresis.
    Ikeda H, Watanabe T, Isoyama K.
    Int J Urol; 2017 Sep; 24(9):698-702. PubMed ID: 28636262
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Development of a Novel Prediction Tool for Response to First-Line Treatments of Monosymptomatic Nocturnal Enuresis: A Randomized, Controlled, International, Multicenter Study (DRYCHILD).
    Jørgensen CS, Dossche L, Zhai R, Maternik M, Kamperis K, Breinbjerg AS, Karamaria S, Thorsteinsson K, Borg B, Wang Y, Li S, Raes A, Wei L, Żurowska A, Hagstrøm S, Walle JV, Guo WJ, Rittig S.
    J Urol; 2024 Oct; 212(4):539-549. PubMed ID: 38950376
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.